Dr James H. Sabry

Dr James H. Sabry

Personal Data

Nationality: Canadian and American
Year of Birth: 1958

Position

Global Head of Pharma Partnering

Studies

  • M.D. - Queen’s University, 1983 (Kingston, Canada)
  • M.Sc. - California Institute of Technology, Biology, 1989 (Pasadena, USA)
  • Ph.D. - University of California, San Francisco, Neuroscience, 1994 (San Francisco, USA)
  • Postdoctoral fellow - Stanford University, Biochemistry, 1994-1998 (Stanford, USA)

Professional Career

  • 1984-1987
    Harvard Medical School (Boston, USA), Resident in Neurology
  • 1987
    Harvard Medical School (Boston, USA), Chief Resident in Neurology
  • 1989-1998
    University of California, San Francisco (San Francisco, USA), Adjunct Clinical Appointment in the Department of Neurology
  • 1997-2006
    Co-founder, President and CEO of Cytokinetics 
  • 2008-2010
    President and CEO of Arete Therapeutics
  • 2010-2013
    Global Head and Vice President of Genentech Partnering, USA
  • 2013-2018
    Global Head and Senior Vice President of Genentech Partnering, USA
  • 2018
    Global Head of Pharma Partnering, Roche Basel, Switzerland

Other Activities / Memberships

  • since 1998
    Member of Scientific Advisory Board at Cytokinetics
  • 2007-2008
    Executive Chairman of the Board of Directors of Cytokinetics
  • 2008-2010
    Chairman of the Board of Directors of Cytokinetics
  • 2005-2016
    Member of the Board of Directors of HopeLab 
  • 2015-2016
    Member of the Board of Directors of California Life Sciences Association
  • since 2016
    Member of the Board of Directors of Coalition for the Life Sciences